These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 31185007)
21. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG Proteins; 1989; 6(1):1-19. PubMed ID: 2558377 [TBL] [Abstract][Full Text] [Related]
22. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Rossmann MG Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708 [TBL] [Abstract][Full Text] [Related]
23. Antiviral therapy for enteroviruses and rhinoviruses. Rotbart HA Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388 [TBL] [Abstract][Full Text] [Related]
24. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193 [TBL] [Abstract][Full Text] [Related]
25. Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders. Morley A; Tomkinson N; Cook A; MacDonald C; Weaver R; King S; Jenkinson L; Unitt J; McCrae C; Phillips T Bioorg Med Chem Lett; 2011 Oct; 21(20):6031-5. PubMed ID: 21907579 [TBL] [Abstract][Full Text] [Related]
26. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509 [TBL] [Abstract][Full Text] [Related]
27. New class of early-stage enterovirus inhibitors with a novel mechanism of action. Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket. Braun H; Kirchmair J; Williamson MJ; Makarov VA; Riabova OB; Glen RC; Sauerbrei A; Schmidtke M Antiviral Res; 2015 Nov; 123():138-45. PubMed ID: 26391975 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771 [TBL] [Abstract][Full Text] [Related]
30. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles. Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091 [TBL] [Abstract][Full Text] [Related]
31. A novel basis of capsid stabilization by antiviral compounds. Phelps DK; Post CB J Mol Biol; 1995 Dec; 254(4):544-51. PubMed ID: 7500332 [TBL] [Abstract][Full Text] [Related]
32. Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders. Fois B; Bianco G; Sonar VP; Distinto S; Maccioni E; Meleddu R; Melis C; Marras L; Pompei R; Floris C; Caboni P; Cottiglia F J Nat Prod; 2017 Oct; 80(10):2799-2806. PubMed ID: 29039946 [TBL] [Abstract][Full Text] [Related]
33. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548 [TBL] [Abstract][Full Text] [Related]
34. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids. Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783 [TBL] [Abstract][Full Text] [Related]
35. Rhinovirus Inhibitors: Including a New Target, the Viral RNA. Real-Hohn A; Blaas D Viruses; 2021 Sep; 13(9):. PubMed ID: 34578365 [TBL] [Abstract][Full Text] [Related]
36. Cryo-EM structure of rhinovirus C15a bound to its cadherin-related protein 3 receptor. Sun Y; Watters K; Hill MG; Fang Q; Liu Y; Kuhn RJ; Klose T; Rossmann MG; Palmenberg AC Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6784-6791. PubMed ID: 32152109 [TBL] [Abstract][Full Text] [Related]
37. Cryo-electron Microscopy Structures of Novel Viruses from Mud Crab Gao Y; Liu S; Huang J; Wang Q; Li K; He J; He J; Weng S; Zhang Q J Virol; 2019 Apr; 93(7):. PubMed ID: 30651355 [TBL] [Abstract][Full Text] [Related]
38. Human rhinovirus 14 complexed with fragments of active antiviral compounds. Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848 [TBL] [Abstract][Full Text] [Related]
39. Atomic structure of a rhinovirus C, a virus species linked to severe childhood asthma. Liu Y; Hill MG; Klose T; Chen Z; Watters K; Bochkov YA; Jiang W; Palmenberg AC; Rossmann MG Proc Natl Acad Sci U S A; 2016 Aug; 113(32):8997-9002. PubMed ID: 27511920 [TBL] [Abstract][Full Text] [Related]
40. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]